Reuters logo
BRIEF-Lexicon reports top-line results from phase 2 clinical trial conducted in collaboration with JDRF
December 5, 2016 / 9:11 PM / 10 months ago

BRIEF-Lexicon reports top-line results from phase 2 clinical trial conducted in collaboration with JDRF

Dec 5 (Reuters) - Lexicon Pharmaceuticals Inc :

* Lexicon reports top-line results from phase 2 clinical trial conducted in collaboration with JDRF

* Lexicon Pharmaceuticals-sotagliflozin was well tolerated in study, smaller proportion of patients experiencing treatment-emergent adverse events

* Results for a1c primary endpoint numerically favored sotagliflozin, but did not reach statistical significance

* Lexicon Pharmaceuticals-patients treated with sotagliflozin achieved mean reduction of 0.62 kg in body weight from baseline to week 12, compared to placebo Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below